AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 29(4), 1980, pp. 638-642
Copyright © 1980 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halstead, S. B.
Right arrow Articles by O'Rourke, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halstead, S. B.
Right arrow Articles by O'Rourke, E. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Dengue

Enhancement of Dengue Virus Infection in Monocytes by Flavivirus Antisera*

Scott B. Halstead, James S. Porterfield AND Edward J. O'Rourke
Department of Tropical Medicine and Medical Microbiology, John A. Burns School of Medicine, University of Hawaii, 3675 Kilauea Avenue, Honolulu, Hawaii 96816, and Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, England

Enhanced dengue 2 virus (D2V) infection in suspension cultures of human peripheral blood mononuclear phagocytes (PBL) produced by subneutralizing concentrations of dengue antisera has been described previously. In this study, the enhancement phenomenon was found to be a general property of representative flavivirus antisera. All except one of 24 antisera, which had been raised by 1–3 injections of flaviviruses in rabbits, enhanced the growth of dengue 2 virus in human PBL. Flavivirus antisera showing the greatest level of cross-reactivity against a battery of 42 flavivirus antigens in the hemagglutination-inhibition test were most potent in enhancing dengue replication in PBL cultures. Cross-neutralizing reactivity did not relate to enhanced D2V infection. However nearly one-half of studied flavivirus antisera neutralized D2V at dilutions of 1:10 or 1:20. Heterotypic D2V neutralizing antibody could serve as a "brake" on infection enhancement in vivo. Observations should be made in the field to look for possible enhancement of dengue infection in heterotypic flavivirus immunes.

Accepted for publication December 1, 1979.


* This research was supported in part by a Fogarty Senior International Fellowship to Scott B. Halstead, M.D., and by a grant from the National Institute of Child Health and Human Development (HD08693).




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
Y. Zhou, M. P. Mammen Jr, C. Klungthong, P. Chinnawirotpisan, D. W. Vaughn, S. Nimmannitya, S. Kalayanarooj, E. C. Holmes, and C. Zhang
Comparative analysis reveals no consistent association between the secondary structure of the 3'-untranslated region of dengue viruses and disease syndrome
J. Gen. Virol., September 1, 2006; 87(9): 2595 - 2603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Society of Tropical Medicine and Hygiene.